Article Text

PDF
Multiprobe fluorescence in situ hybridisation: prognostic perspectives in superficial bladder cancer
  1. C Mian1,
  2. M Lodde2,
  3. E Comploj2,
  4. L Lusuardi2,
  5. S Palermo2,
  6. M Mian2,
  7. K Maier1,
  8. A Pycha2
  1. 1Department of Pathology, Central Hospital of Bolzano, Bolzano, Italy
  2. 2Department of Urology, Central Hospital of Bolzano
  1. Correspondence to:
    C Mian
    Department of Pathology, Central Hospital of Bolzano,L. Boehler St 5, I-39100 Bolzano, Italy;chmian{at}libero.it

Abstract

Aim: To establish independent prognostic factors on a chromosomal basis in superficial bladder cancer, using a multicolour fluorescence in situ hybridisation (FISH) probe mix.

Patients and methods: In 2002, voided urine from 75 consecutive patients (mean age 71.7, range 52–93) years under follow-up for superficial urothelial cancer was studied prospectively. The patients were observed for a mean (standard deviation (SD)) period of 39.3 (6.8) months (range 27–58) until July 2005. A multicolour FISH on liquid-based voided urinary cytology was carried out on all patients. Univariate analysis, using a log rank test, was used to determine the prognostic relevance of a low-risk pattern and a high-risk pattern. Progression-free survival time was calculated from the date of first diagnosis to first recurrence or progression according to the Kaplan–Meier product-limit method.

Results: One patient was lost to follow-up. 27 of the 74 remaining (36.8%) patients showed recurrent disease. In 9 (33.3%) patients with a low-risk pattern disease recurred after a mean (SD) observation time of 29.7 (1.9) months (range 8.3–52.3, median 30.8 (12.4)). 18 (66.7%) patients with a high-risk pattern developed recurrence within a mean (SD) of 17.6 (2.0) months (range 4–38.8, median 16.7 (11.6)). The Kaplan–Meier curve for progression-free survival showed marked differences between the low-risk and the high-risk groups.

Conclusion: Patients with a high-risk chromosomal pattern have a markedly shorter disease-free survival time and higher progression rate than patients with a low-risk pattern. High-risk patients can therefore be treated more aggressively to prevent tumour spreading.

  • Cis, carcinoma in situ
  • FISH, fluorescence in situ hybridisation
  • SSC, sodium saline citrate

Statistics from Altmetric.com

Footnotes

  • Competing interests: None.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.